Patent · US Active

Salt of omecamtiv mecarbil and process for preparing salt

US11472773B2 · kind B2 · utility

13Cited by

20References

20Claims

0Family size

Assignee

CYTOKINETICS, INC. · US

Inventors

Sheng Cui · Lexington, US
Henry Morrison · Dublin, US
Karthik Nagapudi · South San Francisco, US
Shawn D. WALKER · Calabasas, US
Charles Bernard · Moorpark, US
Karl Hansen · Atlantic Highlands, US
Neil Fred Langille · Thousand Oaks, US
Alan Martin Allgeier · Wilmington, US
Steven Mennen · Boston, US
Jacqueline C. S. Woo · Sherwood Park, CA
Bradley Paul Morgan · South San Francisco, US
Alex Muci · South San Francisco, US

Key dates

Filing date	Jul 2, 2020
Grant date	Oct 18, 2022
Priority date	—
Expiry date	Jul 2, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are omecamtiv mecarbil dihydrochloride salt forms, compositions and pharmaceutical formulations thereof, and methods for their preparation and use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.